Literature DB >> 19132227

The effect of plasminogen activator inhibitor type 1 on apoptosis.

David J Schneider1, Yabing Chen, Burton E Sobel.   

Abstract

Plasminogen activator inhibitor type-1 (PAI-1), an inhibitor of plasminogen activators, inhibits formation of plasmin and plasmin-mediated proteolysis. Apoptosis, or programmed cell death, is a potentially important phenomenon in mediating overall cell death. This review focuses on the influence of PAI-1 on apoptosis. Greater expression of PAI-1 has been associated with increased survival of cells and resistance to apoptosis. PAI-1 appears to influence apoptosis by decreasing cell adhesion (anoikis) as well as its effect on intracellular signaling. Mechanisms by which PAI-1 may render a cell resistant to apoptosis include its ability to inhibit generation of plasmin, its ability to inhibit caspase 3, and its ability to inhibit cell adhesion mediated by vitronectin. Inhibition of caspase 3 by PAI-1 may divert intracellular signalling from induction of apoptosis to induction of proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19132227

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  26 in total

1.  Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.

Authors:  Amarnath S Marudamuthu; Shwetha K Shetty; Yashodhar P Bhandary; Sophia Karandashova; Michael Thompson; Venkatachalem Sathish; Galina Florova; Taryn B Hogan; Christina M Pabelick; Y S Prakash; Yoshikazu Tsukasaki; Jian Fu; Mitsuo Ikebe; Steven Idell; Sreerama Shetty
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

2.  Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.

Authors:  Namiko Kobayashi; Toshiharu Ueno; Kumi Ohashi; Hanako Yamashita; Yukina Takahashi; Kazuo Sakamoto; Shun Manabe; Satoshi Hara; Yasutoshi Takashima; Takashi Dan; Ira Pastan; Toshio Miyata; Hidetake Kurihara; Taiji Matsusaka; Jochen Reiser; Michio Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

Review 3.  From genetics to response to injury: vascular smooth muscle cells in aneurysms and dissections of the ascending aorta.

Authors:  Jean-Baptiste Michel; Guillaume Jondeau; Dianna M Milewicz
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

4.  Role of thrombin-activatable fibrinolysis inhibitor in allergic bronchial asthma.

Authors:  Atsushi Fujiwara; Osamu Taguchi; Takehiro Takagi; Corina N D'Alessandro-Gabazza; Daniel Boveda-Ruiz; Masaaki Toda; Atsushi Yasukawa; Yuki Matsushima; Yasushi Miyake; Hiroyasu Kobayashi; Tetsu Kobayashi; Paloma Gil-Bernabe; Masahiro Naito; Masamichi Yoshida; John Morser; Yoshiyuki Takei; Esteban C Gabazza
Journal:  Lung       Date:  2011-10-25       Impact factor: 2.584

5.  Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.

Authors:  Wen-Tan Huang; Praveen K Vayalil; Toshio Miyata; James Hagood; Rui-Ming Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

6.  Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.

Authors:  Evan Gomes-Giacoia; Makito Miyake; Steve Goodison; Charles J Rosser
Journal:  Mol Cancer Ther       Date:  2013-09-26       Impact factor: 6.261

Review 7.  The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding.

Authors:  Marta Helena Kubala; Yves Albert DeClerck
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

8.  Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.

Authors:  Yan Ji; Zhen Weng; Philip Fish; Neha Goyal; Mao Luo; Samantha P Myears; Tammy L Strawn; Bysani Chandrasekar; Jianbo Wu; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-22       Impact factor: 8.311

9.  Design and performance of a turbot (Scophthalmus maximus) oligo-microarray based on ESTs from immune tissues.

Authors:  Adrián Millán; Antonio Gómez-Tato; Carlos Fernández; Belén G Pardo; José A Alvarez-Dios; Manuel Calaza; Carmen Bouza; María Vázquez; Santiago Cabaleiro; Paulino Martínez
Journal:  Mar Biotechnol (NY)       Date:  2009-10-21       Impact factor: 3.619

10.  Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer.

Authors:  Earl Gillespie; Susan E Leeman; Luisa A Watts; Jennifer A Coukos; Michael J O'Brien; Sandra R Cerda; Francis A Farraye; Arthur F Stucchi
Journal:  J Crohns Colitis       Date:  2012-08-23       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.